<body><div><figure><img src="https://img.particlenews.com/image.php?type=thumbnail_580x000&amp;url=1YXFF3_0vmJ0sdw00" alt="https://img.particlenews.com/image.php?url=1YXFF3_0vmJ0sdw00" width="1080" height="630" ></figure>Abington Neurological Associates, one of the largest private neurology practices in Montgomery County, is providing a woman with a new FDA-approved treatment for early symptomatic Alzheimer’s disease.According to NBC10, Karen Chung, 63, of Chester Springs, PA, is one of the first patients in the country to receive the treatment. So far, Chung has received one dose of Kisunla, a treatment for adults with early symptomatic Alzheimer’s disease.“From our perspective, this is a game changer,” said Dr. Dan Gzesh, a neurologist at Abington Neurological Associates. “This class of medicine is the first we’ve been able to offer patients other than enrollment in a clinic trial that can actually treat the underlying process. Before this, all we could do was treat a symptom.”NBC10’s video coverage is below:For more on Abington Neurological Associates, located at 1151 Old York Rd Suite 200, you can visit their website.For all the latest news, follow us on Facebook or sign up for Glenside Local’s “Daily Buzz” newsletter here.Screengrab: NBC10</div></body>

Mountain View, CA

NewsBreak

Abington Neurological Associates doses woman with new FDA-approved treatment for early Alzheimer’s

Abington Neurological Associates, one of the largest private neurology practices in Montgomery County, is providing a woman with a new FDA-approved treatment for early symptomatic Alzheimer’s disease. According to NBC10, Karen Chung, 63, of Chester Springs, PA, is one of the first patients in the country to receive the...